Skip to main content
Top
Published in: Calcified Tissue International 6/2003

01-06-2003 | Clinical Investigations

Suggestive Linkage of 2p22-25 and 11q12-13 with Low Bone Mineral Density at the Lumbar Spine in the Irish Population

Authors: F. Wynne, F. J. Drummond, M. Daly, M. Brown, F. Shanahan, M. G. Molloy, K. A. Quane

Published in: Calcified Tissue International | Issue 6/2003

Login to get access

Abstract

Osteoporosis is a disease characterized by low bone mineral density (BMD) and poor bone quality. Peak bone density is achieved by the third decade of life, after which bone is maintained by a balanced cycle of bone resorption and synthesis. Age-related bone loss occurs as the bone resorption phase outweighs the bone synthesis phase of bone metabolism. Heritability accounts for up to 90% of the variability in BMD. Chromosomal loci including 1p36, 2p22-25, 11q12-13, parathyroid hormone receptor type 1 (PTHR1), interleukin-6 (IL-6), interleukin 1 alpha (IL-1α) and type II collagen A1/vitamin D receptor (COL11A1/VDR) have been linked or shown suggestive linkage with BMD in other populations. To determine whether these loci predispose to low BMD in the Irish population, we investigated 24 microsatellite markers at 7 chromosomal loci by linkage studies in 175 Irish families of probands with primary low BMD (T-score ≤ −1.5). Nonparametric analysis was performed using the maximum likelihood variance estimation and traditional Haseman-Elston tests on the Mapmaker/Sibs program. Suggestive evidence of linkage was observed with lumbar spine BMD at 2p22-25 (maximum LOD score 2.76) and 11q12-13 (MLS 2.55). One region, 1p36, approached suggestive linkage with femoral neck BMD (MLS 2.17). In addition, seven markers achieved LOD scores >1.0, D2S149, D11S1313, D11S987, D11S1314 including those encompassing the PTHR1 (D3S3559, D3S1289) for lumbar spine BMD and D2S149 for femoral neck BMD. Our data suggest that genes within a these chromosomal regions are contributing to a predisposition to low BMD in the Irish population.
Literature
1.
go back to reference Melton, LJ 1995How many women have osteoporosis now?J Bone Miner Res10175177PubMed Melton, LJ 1995How many women have osteoporosis now?J Bone Miner Res10175177PubMed
2.
go back to reference Ray, NF, Chan, JK, Thamer, M, Melton III, LJ 1997Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation.J Bone Miner Res122435PubMed Ray, NF, Chan, JK, Thamer, M, Melton III, LJ 1997Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation.J Bone Miner Res122435PubMed
3.
go back to reference Randell, A, Sambrook, PN, Nguyen, TV, Lapsley, H, Jones, G, Kelly, PJ, Eisman, JA 1995Direct clinical and welfare costs of osteoporotic fractures in elderly men and women.Osteoporos Int5427432PubMed Randell, A, Sambrook, PN, Nguyen, TV, Lapsley, H, Jones, G, Kelly, PJ, Eisman, JA 1995Direct clinical and welfare costs of osteoporotic fractures in elderly men and women.Osteoporos Int5427432PubMed
4.
go back to reference Pocock, NA, Eisman, JA, Hopper, JL, Yeats, MG, Sambrook, PM, Eberl, S 1987Genetic determinants of bone mass in adults. A twin study.J Clin Invest80706710PubMed Pocock, NA, Eisman, JA, Hopper, JL, Yeats, MG, Sambrook, PM, Eberl, S 1987Genetic determinants of bone mass in adults. A twin study.J Clin Invest80706710PubMed
5.
go back to reference Smith, DM, Nance, WE, Kang, KW, Christian, JC, Johnston Jr, CC 1973Genetic factors in determining bone mass.J Clin Invest5228002808PubMed Smith, DM, Nance, WE, Kang, KW, Christian, JC, Johnston Jr, CC 1973Genetic factors in determining bone mass.J Clin Invest5228002808PubMed
6.
go back to reference Duncan, EL, Sinsheimer, J, Dymott, K, Jakobsen, B, Shipman, AJ, Wass, JAH 1997Bone mineral density of relatives of male and female patients with osteoporosis.J Endocrinol152S11 Duncan, EL, Sinsheimer, J, Dymott, K, Jakobsen, B, Shipman, AJ, Wass, JAH 1997Bone mineral density of relatives of male and female patients with osteoporosis.J Endocrinol152S11
7.
go back to reference Cummings, SR, Nevitt, MC, Browner, WS, Stone, K, Fox, KM, Ensrud, KE, Cauley, J, Black, D, Vogt, TM 1995Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group.N Engl J Med332767773PubMed Cummings, SR, Nevitt, MC, Browner, WS, Stone, K, Fox, KM, Ensrud, KE, Cauley, J, Black, D, Vogt, TM 1995Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group.N Engl J Med332767773PubMed
8.
go back to reference Torgerson, DJ, Campbell, MK, Thomas, RE, Reid, DM 1996Prediction of perimenopausal fractures by bone mineral density and other risk factors.J Bone Miner Res11293297PubMed Torgerson, DJ, Campbell, MK, Thomas, RE, Reid, DM 1996Prediction of perimenopausal fractures by bone mineral density and other risk factors.J Bone Miner Res11293297PubMed
9.
go back to reference Efstathiadou, Z, Tsatsoulis, A, Loannidis, J 2001Association of collagen 1α 1 Spl polymorphism with the Risk of prevalent fractures: a meta-analysis.J Bone Miner Res1615861592PubMed Efstathiadou, Z, Tsatsoulis, A, Loannidis, J 2001Association of collagen 1α 1 Spl polymorphism with the Risk of prevalent fractures: a meta-analysis.J Bone Miner Res1615861592PubMed
10.
go back to reference Gross, C, Eccleshall, TR, Malloy, PJ, Villa, ML, Marcus, R, Feldman, D 1996The presence of a polymorphism at the translation initiation site of the vitamin D receptor gene is associated with low bone mineral density in postmenopausal Mexican-American women.J Bone Miner Res1118501815PubMed Gross, C, Eccleshall, TR, Malloy, PJ, Villa, ML, Marcus, R, Feldman, D 1996The presence of a polymorphism at the translation initiation site of the vitamin D receptor gene is associated with low bone mineral density in postmenopausal Mexican-American women.J Bone Miner Res1118501815PubMed
11.
go back to reference Sano, M, Inoue, S, Hosoi, T, Ouchi, Y, Emi, M, Shiraki, M, Orimo, H 1995Association of estrogen receptor dinucleotide repeat polymorphism with osteoporosis.Biochem Biophys Res Commun217378383PubMed Sano, M, Inoue, S, Hosoi, T, Ouchi, Y, Emi, M, Shiraki, M, Orimo, H 1995Association of estrogen receptor dinucleotide repeat polymorphism with osteoporosis.Biochem Biophys Res Commun217378383PubMed
12.
go back to reference Ota, N, Nakajima, T, Nakazawa, I, Suzuki, T, Hosoi, T, Orimo, H, Inoue, S, Shirai, Y, Emi, M 2001A nucleotide variant in the promoter region of the interleukin-6 gene associated with decreased bone mineral density.J Hum Genet46267272 Ota, N, Nakajima, T, Nakazawa, I, Suzuki, T, Hosoi, T, Orimo, H, Inoue, S, Shirai, Y, Emi, M 2001A nucleotide variant in the promoter region of the interleukin-6 gene associated with decreased bone mineral density.J Hum Genet46267272
13.
go back to reference Tsukamoto, K, Ohta, N, Shirai, Y, Emi, M 1998A highly polymorphic CA repeat marker at the human interleukin 6 receptor (IL6R) locus.J Hum Genet43289290CrossRefPubMed Tsukamoto, K, Ohta, N, Shirai, Y, Emi, M 1998A highly polymorphic CA repeat marker at the human interleukin 6 receptor (IL6R) locus.J Hum Genet43289290CrossRefPubMed
14.
go back to reference Langdahl, BL, Knudsen, JY, Jensen, HK, Gregersen, N, Eriksen, EF 1997A sequence variation: 713-8delC in the transforming growth factor-beta 1 gene has higher prevalence in osteoporotic women than in normal women and is associated with very low bone mass in osteoporotic women and increased bone turnover in both osteoporotic and normal women.Bone20289294PubMed Langdahl, BL, Knudsen, JY, Jensen, HK, Gregersen, N, Eriksen, EF 1997A sequence variation: 713-8delC in the transforming growth factor-beta 1 gene has higher prevalence in osteoporotic women than in normal women and is associated with very low bone mass in osteoporotic women and increased bone turnover in both osteoporotic and normal women.Bone20289294PubMed
15.
go back to reference Wynne, F, Drummond, F, O’Sullivan, K, Daly, M, Shannahan, F, Molloy, MG, Quane, KA 2002An investigation of the influence of the OPG gene, VDR (Fok1) and COLIA1 Sp1 polymorphisms on BMD in the Irish population.Calcif Tissue Int712635CrossRefPubMed Wynne, F, Drummond, F, O’Sullivan, K, Daly, M, Shannahan, F, Molloy, MG, Quane, KA 2002An investigation of the influence of the OPG gene, VDR (Fok1) and COLIA1 Sp1 polymorphisms on BMD in the Irish population.Calcif Tissue Int712635CrossRefPubMed
16.
go back to reference Devoto, M, Shimoya, K, Caminis, J, Ott, J, Tenenhouse, A, Whyte, MP, Sereda, L, Hall, S, Considine, E, Williams, CJ, Tromp, G, Kuivaniemi, H, Ala-Kokko, L, Prockop, DJ, Spotila, LD 1998First-stage autosomal genome screen in extended pedigrees suggests genes predisposing to low bone mineral density on chromosomes 1p, 2p and 4p.Eur J Hum Genet6151157PubMed Devoto, M, Shimoya, K, Caminis, J, Ott, J, Tenenhouse, A, Whyte, MP, Sereda, L, Hall, S, Considine, E, Williams, CJ, Tromp, G, Kuivaniemi, H, Ala-Kokko, L, Prockop, DJ, Spotila, LD 1998First-stage autosomal genome screen in extended pedigrees suggests genes predisposing to low bone mineral density on chromosomes 1p, 2p and 4p.Eur J Hum Genet6151157PubMed
17.
go back to reference Johnson, ML, Gong, G, Kimberling, W, Recker, SM, Kimmel, DB, Recker, R 1997Linkage of a gene causing high bone mass to human chromosome 11 (11q12-13).Am J Hum Genet6013261332PubMed Johnson, ML, Gong, G, Kimberling, W, Recker, SM, Kimmel, DB, Recker, R 1997Linkage of a gene causing high bone mass to human chromosome 11 (11q12-13).Am J Hum Genet6013261332PubMed
18.
go back to reference Koller, DL, Rodriguez, J, Christain, C, Siemenda, M, Econs, S, Hui, P, Morin, P, Conneally, G, Joslyn, M, Curran, M, Paecock, C, Johnson, C, Foroud, T 1998Linkage of a QTL contributing to normal variation in bone mineral density to chromosome 11q12-13.J Bone Miner Res1319031908PubMed Koller, DL, Rodriguez, J, Christain, C, Siemenda, M, Econs, S, Hui, P, Morin, P, Conneally, G, Joslyn, M, Curran, M, Paecock, C, Johnson, C, Foroud, T 1998Linkage of a QTL contributing to normal variation in bone mineral density to chromosome 11q12-13.J Bone Miner Res1319031908PubMed
19.
go back to reference Heaney, C, Shaley, H, Elbedour, K, Carmi, R, Staack, JB, Sheffield, VC, Beier, DR 1998Human autosomal recessive osteopetrosis maps to 11q13, a position predicted by comparative mapping of the murine osteosclerosis (oc) mutation.Hum Mol Genet714071410CrossRefPubMed Heaney, C, Shaley, H, Elbedour, K, Carmi, R, Staack, JB, Sheffield, VC, Beier, DR 1998Human autosomal recessive osteopetrosis maps to 11q13, a position predicted by comparative mapping of the murine osteosclerosis (oc) mutation.Hum Mol Genet714071410CrossRefPubMed
20.
go back to reference Gong, Y, Vikkula, M, Boon, L, Liu, J, Beighton, P, Ramesar, R, Peltonen, L, Somer, H, Hirose, T, Dallapiccola, B, De Paepe, A, Swoboda, W, Zabel, B, Superti-Furga, A, Steinmann, B, Brunner, HG, Jans, A, Boles, RG, Adkins, W, van den Boogaard, MJ, Olsen, BR, Warman, ML 1996Osteoporosis-pseudoglioma syndrome, a disorder affecting skeletal strength and vision, is assigned to chromosome region 11q12-13.Am J Hum Genet59146151PubMed Gong, Y, Vikkula, M, Boon, L, Liu, J, Beighton, P, Ramesar, R, Peltonen, L, Somer, H, Hirose, T, Dallapiccola, B, De Paepe, A, Swoboda, W, Zabel, B, Superti-Furga, A, Steinmann, B, Brunner, HG, Jans, A, Boles, RG, Adkins, W, van den Boogaard, MJ, Olsen, BR, Warman, ML 1996Osteoporosis-pseudoglioma syndrome, a disorder affecting skeletal strength and vision, is assigned to chromosome region 11q12-13.Am J Hum Genet59146151PubMed
21.
go back to reference Van Hul, E, Gram, J, Bollerslev, J, Van Wesenbeeck, L, Mathysen, D, Andersen, PE, Vanhoenacker, F, Van Hul, W 2002Localization of the gene causing autosomal dominant osteopetrosis type 1 to chromosome 11q12-13.J Bone Miner Res1711111117PubMed Van Hul, E, Gram, J, Bollerslev, J, Van Wesenbeeck, L, Mathysen, D, Andersen, PE, Vanhoenacker, F, Van Hul, W 2002Localization of the gene causing autosomal dominant osteopetrosis type 1 to chromosome 11q12-13.J Bone Miner Res1711111117PubMed
22.
go back to reference Little, RD, Carulli, JP, Del Mastro, RG, et al. 2002A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait.Am J Hum Genet701119CrossRefPubMed Little, RD, Carulli, JP, Del Mastro, RG,  et al. 2002A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait.Am J Hum Genet701119CrossRefPubMed
23.
go back to reference Gong, Y, Slee, RB, Fukai, N, Rawadi, G, et al. 2001LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development.Cell107513523PubMed Gong, Y, Slee, RB, Fukai, N, Rawadi, G,  et al. 2001LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development.Cell107513523PubMed
24.
go back to reference Frattini, A, Orchard, PJ, Sobacchi, C, Giliani, S, Abinun, M, Mattsson, JP, Keeling, DJ, Andersson, AK, Wallbrandt, P, Zecca, L, Notarangelo, LD, Vezzoni, P, Villa, A 2000Defects in TCIRG1 subunit of the vacuolar proton pump are responsible for a subset of human autosomal recessive osteopetrosis.Nat Genet25343346PubMed Frattini, A, Orchard, PJ, Sobacchi, C, Giliani, S, Abinun, M, Mattsson, JP, Keeling, DJ, Andersson, AK, Wallbrandt, P, Zecca, L, Notarangelo, LD, Vezzoni, P, Villa, A 2000Defects in TCIRG1 subunit of the vacuolar proton pump are responsible for a subset of human autosomal recessive osteopetrosis.Nat Genet25343346PubMed
25.
go back to reference Duncan, EL, Brown, MA, Sinsheimer, J, Bell, J, Carr, AJ, Wordsworth, BP, Wass, JA 1999Suggestive linkage of the parathyroid receptor type 1 to osteoporosis.J Bone Miner Res1419931999PubMed Duncan, EL, Brown, MA, Sinsheimer, J, Bell, J, Carr, AJ, Wordsworth, BP, Wass, JA 1999Suggestive linkage of the parathyroid receptor type 1 to osteoporosis.J Bone Miner Res1419931999PubMed
26.
go back to reference Niu, T, Cehn, C, Cordell, H, Yang, J, Wang, B, Wang, Z, Fang, Z, Schork, NJ, Rosen, CJ, Xu, X 1999A genome-wide scan for loci linked to forearm bone mineral density.Hum Genet104226233CrossRefPubMed Niu, T, Cehn, C, Cordell, H, Yang, J, Wang, B, Wang, Z, Fang, Z, Schork, NJ, Rosen, CJ, Xu, X 1999A genome-wide scan for loci linked to forearm bone mineral density.Hum Genet104226233CrossRefPubMed
27.
go back to reference Devoto, M, Specchia, C, Hui-Hua, L, Caminis, J, Tenenhouse, A, Rodriguez, H, Spotila, L 2001Variance component linkage analysis indicates a QTL for femoral neck bone mineral density on chromosome 1p36.Hum Mol Gen1024472452CrossRefPubMed Devoto, M, Specchia, C, Hui-Hua, L, Caminis, J, Tenenhouse, A, Rodriguez, H, Spotila, L 2001Variance component linkage analysis indicates a QTL for femoral neck bone mineral density on chromosome 1p36.Hum Mol Gen1024472452CrossRefPubMed
28.
go back to reference Kanis, JA, Melton Jr, L, Christiansen, C, Johnston, CC, Khaltaev, N 1994The diagnosis of osteoporosis.J Bone Miner Res911371141PubMed Kanis, JA, Melton Jr, L, Christiansen, C, Johnston, CC, Khaltaev, N 1994The diagnosis of osteoporosis.J Bone Miner Res911371141PubMed
29.
go back to reference Old, JM 1983Methods in haematology.Churchill-LivingstonEdinburg Old, JM 1983Methods in haematology.Churchill-LivingstonEdinburg
30.
go back to reference O’Connell, JR, Weeks, DE 1998Pedcheck: a program for identification of genotype incompatibilities in linkage analysis.Am J Hum Genet63259266PubMed O’Connell, JR, Weeks, DE 1998Pedcheck: a program for identification of genotype incompatibilities in linkage analysis.Am J Hum Genet63259266PubMed
31.
go back to reference Haseman, J, Elston, R 1972The investigation of linkage between a quantitative trait and a marker locus.Behav Genet2319PubMed Haseman, J, Elston, R 1972The investigation of linkage between a quantitative trait and a marker locus.Behav Genet2319PubMed
32.
go back to reference Kruglyak, L, Lander, E 1995Complete multipoint sib-pair analysis of qualitative and quantitative traits.Am J Hum Genet57439454PubMed Kruglyak, L, Lander, E 1995Complete multipoint sib-pair analysis of qualitative and quantitative traits.Am J Hum Genet57439454PubMed
33.
go back to reference Almasy, L, Blangero, J 1998Multipoint quantitative-trait linkage analysis in general pedigrees.Am J Hum Genet6211981211PubMed Almasy, L, Blangero, J 1998Multipoint quantitative-trait linkage analysis in general pedigrees.Am J Hum Genet6211981211PubMed
34.
go back to reference Slager, S, Vieland, V 1997Investigating the numerical effect of ascertainment bias in linkage analysis: development of methods and primary results.Genet Epididemiol1411191124CrossRef Slager, S, Vieland, V 1997Investigating the numerical effect of ascertainment bias in linkage analysis: development of methods and primary results.Genet Epididemiol1411191124CrossRef
35.
go back to reference Lyengar, S, Calafell, F, Kidd, K 1997Detection of major genes underlying several quantitative traits associated with a common disease using different ascertainment schemes.Genet Epid14809814CrossRef Lyengar, S, Calafell, F, Kidd, K 1997Detection of major genes underlying several quantitative traits associated with a common disease using different ascertainment schemes.Genet Epid14809814CrossRef
36.
go back to reference Lander, E, Kruglyak, L 1995Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results.Nature Genet11241247PubMed Lander, E, Kruglyak, L 1995Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results.Nature Genet11241247PubMed
37.
go back to reference Nicole, S, Davoine, CS, Topaloglu, H, et al. 2000Perlecan, the major proteoglycan of basement membranes, is altered in patients with Schwartz-Jampel syndrome (chondrodystrophic myotonia).Nat Genet26480483 Nicole, S, Davoine, CS, Topaloglu, H,  et al. 2000Perlecan, the major proteoglycan of basement membranes, is altered in patients with Schwartz-Jampel syndrome (chondrodystrophic myotonia).Nat Genet26480483
38.
go back to reference Kumar, R, Haugen, JD 1994Human and rat osteoblast-like cells express stathmin, a growth-regulatory protein.Biochem Biophys Res Commun201861865CrossRefPubMed Kumar, R, Haugen, JD 1994Human and rat osteoblast-like cells express stathmin, a growth-regulatory protein.Biochem Biophys Res Commun201861865CrossRefPubMed
39.
go back to reference Cook, T, Gebelein, B, Mesa, K, Mladek, A, Urrutia, R 1998Molecular cloning and characterisation of TIEG2 reveals a new subfamily of transforming growth factor-beta-inducible Sp1-like zinc finger-encoding genes involved in the regulation of cell growth.J Biol Chem2732592925936CrossRefPubMed Cook, T, Gebelein, B, Mesa, K, Mladek, A, Urrutia, R 1998Molecular cloning and characterisation of TIEG2 reveals a new subfamily of transforming growth factor-beta-inducible Sp1-like zinc finger-encoding genes involved in the regulation of cell growth.J Biol Chem2732592925936CrossRefPubMed
40.
go back to reference Krude, H, Biebermann, H, Luck, W, Horn, R, Brabant, G, Gruters, A 1998Severe early-onset obesity, adrenal insufficiency and red pigmentation caused by POMC mutations in humans.Nat Genet19155157CrossRefPubMed Krude, H, Biebermann, H, Luck, W, Horn, R, Brabant, G, Gruters, A 1998Severe early-onset obesity, adrenal insufficiency and red pigmentation caused by POMC mutations in humans.Nat Genet19155157CrossRefPubMed
41.
go back to reference Sobacchi, C, Frattini, A, Orchard, P, Porras, O, et al. 2001The mutational spectrum of human malignant autosomal recessive osteopetrosis.Hum Mol Genet1017671773PubMed Sobacchi, C, Frattini, A, Orchard, P, Porras, O,  et al. 2001The mutational spectrum of human malignant autosomal recessive osteopetrosis.Hum Mol Genet1017671773PubMed
42.
go back to reference Johnson, RS, Spiegelman, BM, Papaioannou, V 1992Pleiotropic effects of a null mutation in the c-fos proto-oncogene.Cell71577586PubMed Johnson, RS, Spiegelman, BM, Papaioannou, V 1992Pleiotropic effects of a null mutation in the c-fos proto-oncogene.Cell71577586PubMed
43.
go back to reference Matsuo, K, Owens, JM, Tonko, M, Elliott, C, Chambers, TJ, Wagner, EF 2000Fos11 is a transcriptional target of c-Fos during osteoclast differentiation.Nat Genet24184187CrossRefPubMed Matsuo, K, Owens, JM, Tonko, M, Elliott, C, Chambers, TJ, Wagner, EF 2000Fos11 is a transcriptional target of c-Fos during osteoclast differentiation.Nat Genet24184187CrossRefPubMed
44.
go back to reference Schipani, E, Landman, C, Parfitt, A, Jansen, G, Kikuchi, S, Kooh, S, Cole, W, Juppner, H 1996Constitutively activated receptors for parathyroid hormone and parathyroid hormone-related peptide in Jansen’s metaphyseal chondrodysplasia.N Engl J Med335708714PubMed Schipani, E, Landman, C, Parfitt, A, Jansen, G, Kikuchi, S, Kooh, S, Cole, W, Juppner, H 1996Constitutively activated receptors for parathyroid hormone and parathyroid hormone-related peptide in Jansen’s metaphyseal chondrodysplasia.N Engl J Med335708714PubMed
45.
go back to reference Kruse, K, Schutz, C 1993Calcium metabolism in the Jansen type of metaphyseal dysphyseal.Eur J Pediatr152912915PubMed Kruse, K, Schutz, C 1993Calcium metabolism in the Jansen type of metaphyseal dysphyseal.Eur J Pediatr152912915PubMed
46.
go back to reference Zee, RYL, Myers, RH, Hannan, MT, Wilson, PWF, Ordovas, JM, Schaefer, EJ, Lindpaintner, K, Kiel, DP 2000Absence of linkage for bone mineral density to chromosome 12q12-14 in the region of the vitamin D receptor gene.Calcif Tissue Int67434439CrossRefPubMed Zee, RYL, Myers, RH, Hannan, MT, Wilson, PWF, Ordovas, JM, Schaefer, EJ, Lindpaintner, K, Kiel, DP 2000Absence of linkage for bone mineral density to chromosome 12q12-14 in the region of the vitamin D receptor gene.Calcif Tissue Int67434439CrossRefPubMed
Metadata
Title
Suggestive Linkage of 2p22-25 and 11q12-13 with Low Bone Mineral Density at the Lumbar Spine in the Irish Population
Authors
F. Wynne
F. J. Drummond
M. Daly
M. Brown
F. Shanahan
M. G. Molloy
K. A. Quane
Publication date
01-06-2003
Publisher
Springer-Verlag
Published in
Calcified Tissue International / Issue 6/2003
Print ISSN: 0171-967X
Electronic ISSN: 1432-0827
DOI
https://doi.org/10.1007/s00223-002-2086-2

Other articles of this Issue 6/2003

Calcified Tissue International 6/2003 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine